Applied Genomics

Pulmotype is a five antibody immunohistochemistry test used to aid the pathologist in the diagnosis of adenocarcinoma from squamous cell carcinoma of non-small cell lung cancer. Proper diagnosis is critical for determining therapy options. To find out more about Pulmotype click here.

Mammostrat is a novel molecular-targeted immunohistochemistry test for the risk profiling of ER+ breast cancer patients. To find out more about Mammostrat click here.

Applied Genomics has been acquired by Clarient Inc., a leading provider of cancer diagnostic testing.

AGI’s taxane sensitivity marker, Mammotax, recently published in Breast Cancer Research. Mammotax is a single antibody immunohistochemistry test for assessing whether a patient will respond to taxane therapy. A discovery and validation study were published in the March 23 issue of Breast Cancer Research. AGI is currently evaluating Mammotax in several additional independent clinical cohorts.